A detailed history of Jpmorgan Chase & CO transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,538,322 shares of JAZZ stock, worth $168 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,538,322
Previous 1,494,538 2.93%
Holding current value
$168 Million
Previous $180 Million 8.77%
% of portfolio
0.01%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$103.94 - $118.98 $4.55 Million - $5.21 Million
43,784 Added 2.93%
1,538,322 $164 Million
Q1 2024

May 10, 2024

BUY
$115.19 - $132.77 $11.2 Million - $12.9 Million
97,254 Added 6.96%
1,494,538 $180 Million
Q4 2023

Feb 12, 2024

SELL
$114.26 - $136.0 $3.29 Million - $3.91 Million
-28,757 Reduced 2.02%
1,397,284 $172 Million
Q3 2023

Nov 14, 2023

SELL
$122.0 - $145.31 $33.1 Million - $39.4 Million
-270,971 Reduced 15.97%
1,426,041 $185 Million
Q2 2023

Aug 11, 2023

SELL
$122.5 - $147.16 $52.8 Million - $63.4 Million
-430,992 Reduced 20.25%
1,697,012 $210 Million
Q1 2023

May 18, 2023

BUY
$133.98 - $160.47 $10.1 Million - $12.1 Million
75,616 Added 3.68%
2,128,004 $311 Million
Q1 2023

May 11, 2023

SELL
$133.98 - $160.47 $107 Million - $128 Million
-799,106 Reduced 28.02%
2,052,388 $300 Million
Q4 2022

Feb 13, 2023

SELL
$129.72 - $159.85 $85.5 Million - $105 Million
-659,347 Reduced 18.78%
2,851,494 $454 Million
Q3 2022

Nov 14, 2022

BUY
$126.59 - $161.18 $16.9 Million - $21.6 Million
133,780 Added 3.96%
3,510,841 $468 Million
Q2 2022

Aug 11, 2022

BUY
$141.59 - $168.66 $12.4 Million - $14.8 Million
87,895 Added 2.67%
3,377,061 $527 Million
Q1 2022

May 11, 2022

BUY
$129.64 - $160.7 $8.73 Million - $10.8 Million
67,374 Added 2.09%
3,289,166 $512 Million
Q4 2021

Feb 10, 2022

BUY
$119.87 - $145.67 $39 Million - $47.4 Million
325,479 Added 11.24%
3,221,792 $410 Million
Q3 2021

Nov 12, 2021

BUY
$128.64 - $184.79 $373 Million - $535 Million
2,896,313 New
2,896,313 $377 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $6.86B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.